Recent events
Recent events tied to this brand in public sources.
Back to profile13 entries
2026
AbCellera launches $200m public offering to fund ABCL635 menopause antibody
AbCellera Biologics launched an underwritten public offering to raise $200 million through common shares and pre-funded warrants, with net proceeds intended to support clinical advancement of its lead program ABCL635, a non-hormonal antibody for moderate-to-severe vasomotor symptoms caused by menopause.
2021
Shavelogic raises $100 million in growth capital
Shavelogic announced that it had raised $100 million in growth capital from Jefferies. Aon's Intellectual Property Solutions helped secure collateral protection insurance to support the financing.
2021
Stevanato Group announces proposed IPO roadshow
Stevanato Group announced plans to commence a roadshow for a proposed IPO of 40,000,000 ordinary shares and said it had applied to list the shares on the New York Stock Exchange.
2021
Trumid and Jefferies collaborate on emerging-markets credit trading
Trumid announced that it would collaborate with Jefferies on emerging-markets credit trading. Jefferies will use Trumid's Attributed Trading protocol and workflow solutions to provide liquidity to its institutional clients.
2020
Jefferies and KB Securities establish a co-brand alliance in South Korea
Jefferies announced that it had established a co-brand alliance with KB Securities covering equity research, sales and trading in South Korea. Jefferies will distribute KB Securities-produced research to its global clients, and KB Securities will provide local equity brokerage services to Jefferies and its international clients.
2020
Kodiak Sciences announces public stock offering
Kodiak Sciences announced the pricing of an underwritten public offering of 5,193,237 common shares at $108 per share, with gross proceeds expected to be approximately $560.9 million. The offering was expected to close on or about November 20, 2020, subject to customary closing conditions.
2020
BELLUS Health prices public offering
BELLUS Health announced that it had entered into an underwriting agreement for a public offering of 15,555,556 common shares at US$2.25 per share. Closing was expected on October 22, 2020, subject to customary conditions.
2020
Jefferies and Regis Partners establish a co-brand agreement in the Philippines
Jefferies Hong Kong Limited announced a co-brand agreement with Regis Partners for cash equities in the Philippines. Jefferies will distribute co-branded equity research to its global clients, while Regis Partners will provide local equity broking services.
2020
Jefferies Group announces Matthew Larson as CFO
Jefferies Group announced that Matthew Larson will become its Chief Financial Officer effective August 24, 2020, succeeding interim CFO Teresa Gendron.
2019
Constellation Pharmaceuticals prices public stock offering
Constellation Pharmaceuticals announced the pricing of an underwritten public offering of 6.5 million common shares at $34.50 per share, for gross proceeds of $224.3 million before deductions. The offering was expected to close on December 13, 2019, subject to customary closing conditions.
2019
Arrowhead Pharmaceuticals prices public stock offering
Arrowhead Pharmaceuticals announced the pricing of an underwritten public offering of 4 million common shares at $58 per share. The offering was expected to close on or about December 6, 2019, subject to customary closing conditions.
2019
Kodiak Sciences prices public stock offering
Kodiak Sciences announced the pricing of an underwritten public offering of 6,000,000 common shares at $46 per share, with expected gross proceeds of approximately $276 million before expenses.
2019
Danaos prices public offering of common stock
Danaos Corporation announced that its offering of 9,000,000 common shares was priced at $6.00 per share; gross proceeds before expenses were expected to be approximately $54 million.